These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3893211)
21. Priming and the onset of neuromuscular blockade with alcuronium. Black AM; Hutton P; el-Hassan KM; Morgan G; Clutton-Brock TH Br J Anaesth; 1986 Aug; 58(8):827-33. PubMed ID: 3730230 [TBL] [Abstract][Full Text] [Related]
22. Committee on Safety of Medicines. Scowen E Br J Anaesth; 1978 Dec; 50(12):1270. PubMed ID: 747705 [No Abstract] [Full Text] [Related]
23. [Is there any relationship between myasthenia gravis and disseminated lupus erythematosus?]. Fucík J; Strejcek J Munch Med Wochenschr; 1970 Jul; 112(31):1408-11. PubMed ID: 4194245 [No Abstract] [Full Text] [Related]
24. Dose-response curves for alcuronium and pancuronium alone and in combination. Shanks CA Anaesth Intensive Care; 1982 Aug; 10(3):248-51. PubMed ID: 7125191 [TBL] [Abstract][Full Text] [Related]
25. Improvement of myasthenia gravis by hemodialysis in a patient with chronic renal failure. Hedger RW; Davis FA; Schwartz FD; Ing TS Ann Intern Med; 1971 Nov; 75(5):749-52. PubMed ID: 4941439 [No Abstract] [Full Text] [Related]
26. [Myasthenia gravis and LE nephritis: problems of treatment with cholinesterase inhibitors during long-term dialysis (author's transl)]. Korz R; Klein H; Genth E Dtsch Med Wochenschr; 1978 Sep; 103(38):1485-8. PubMed ID: 688880 [No Abstract] [Full Text] [Related]
30. Adverse reactions to atracurium and alcuronium. A prospective surveillance study. Beemer GH; Dennis WL; Platt PR; Bjorksten AR; Carr AB Br J Anaesth; 1988 Dec; 61(6):680-4. PubMed ID: 2974714 [TBL] [Abstract][Full Text] [Related]
31. Myasthenic crisis after a renal transplant successfully treated with intravenous immunoglobulin. Hwang IH; Lee KN; Kim IY; Lee DW; Lee SB; Kim DS; Song SH; Seong EY; Kwak IS Exp Clin Transplant; 2014 Dec; 12(6):555-8. PubMed ID: 24568644 [TBL] [Abstract][Full Text] [Related]
33. Comparative clinical features in patients with myasthenia gravis with systemic lupus erythematosus. Chan MK; Britton M J Rheumatol; 1980; 7(6):838-42. PubMed ID: 7205824 [TBL] [Abstract][Full Text] [Related]
34. Allergic reactions to intravenous anaesthetic induction agents and muscle relaxants. Case reports and a clinical review. Shipton EA; Roelofse JA S Afr Med J; 1985 Jun; 67(25):1023-5. PubMed ID: 4012469 [TBL] [Abstract][Full Text] [Related]
35. Effect of ethanol on neuromuscular function in rats. Its interaction with alcuronium. Borges R; Feria M; Díaz E; Rodríguez Méndez SA; Boada J Gen Pharmacol; 1986; 17(5):569-72. PubMed ID: 3781208 [TBL] [Abstract][Full Text] [Related]
36. [Systemic lupus erythematosus associated with myasthenia gravis: presentation of a case and review of the literature]. Martínez Matos JA; Reñé R; Vila MJ; Mauri JM; Montero J; Pintó J Neurologia; 1987; 2(3):139-42. PubMed ID: 3079000 [No Abstract] [Full Text] [Related]
37. The effect of halothane on the action of alcuronium in the dog. Jones RS; Heckmann R; Wuersch W Experientia; 1979 Sep; 35(9):1209-10. PubMed ID: 226397 [TBL] [Abstract][Full Text] [Related]